Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

被引:1686
作者
Jacinto, E
Loewith, R
Schmidt, A
Lin, S
Rüegg, MA
Hall, A
Hall, MN
机构
[1] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland
[2] UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England
关键词
D O I
10.1038/ncb1183
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The target of rapamycin ( TOR) is a highly conserved protein kinase and a central controller of cell growth. In budding yeast, TOR is found in structurally and functionally distinct protein complexes: TORC1 and TORC2. A mammalian counterpart of TORC1 (mTORC1) has been described, but it is not known whether TORC2 is conserved in mammals. Here, we report that a mammalian counterpart of TORC2 (mTORC2) also exists. mTORC2 contains mTOR, mLST8 and mAVO3, but not raptor. Like yeast TORC2, mTORC2 is rapamycin insensitive and seems to function upstream of Rho GTPases to regulate the actin cytoskeleton. mTORC2 is not upstream of the mTORC1 effector S6K. Thus, two distinct TOR complexes constitute a primordial signalling network conserved in eukaryotic evolution to control the fundamental process of cell growth.
引用
收藏
页码:1122 / U30
页数:10
相关论文
共 31 条
  • [1] Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration
    Astrinidis, A
    Cash, TP
    Hunter, DS
    Walker, CL
    Chernoff, J
    Henske, EP
    [J]. ONCOGENE, 2002, 21 (55) : 8470 - 8476
  • [2] Azim AC, 2000, METHOD ENZYMOL, V325, P257
  • [3] A system for stable expression of short interfering RNAs in mammalian cells
    Brummelkamp, TR
    Bernards, R
    Agami, R
    [J]. SCIENCE, 2002, 296 (5567) : 550 - 553
  • [4] Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002
    Brunn, GJ
    Williams, J
    Sabers, C
    Wiederrecht, G
    Lawrence, JC
    Abraham, RT
    [J]. EMBO JOURNAL, 1996, 15 (19) : 5256 - 5267
  • [5] The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1
    Chou, MM
    Blenis, J
    [J]. CELL, 1996, 85 (04) : 573 - 583
  • [6] Specificity and mechanism of action of some commonly used protein kinase inhibitors
    Davies, SP
    Reddy, H
    Caivano, M
    Cohen, P
    [J]. BIOCHEMICAL JOURNAL, 2000, 351 (351) : 95 - 105
  • [7] Mammalian TOR: A homeostatic ATP sensor
    Dennis, PB
    Jaeschke, A
    Saitoh, M
    Fowler, B
    Kozma, SC
    Thomas, G
    [J]. SCIENCE, 2001, 294 (5544) : 1102 - 1105
  • [8] Rho GTPases in cell biology
    Etienne-Manneville, S
    Hall, A
    [J]. NATURE, 2002, 420 (6916) : 629 - 635
  • [9] PLD1 regulates mTOR signaling and mediates Cdc42 activation of S6K1
    Fang, YM
    Park, IH
    Wu, AL
    Du, GW
    Huang, P
    Frohman, MA
    Walker, SJ
    Brown, HA
    Chen, J
    [J]. CURRENT BIOLOGY, 2003, 13 (23) : 2037 - 2044
  • [10] Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
    Fingar, DC
    Blenis, J
    [J]. ONCOGENE, 2004, 23 (18) : 3151 - 3171